Tumor necrosis factor - Related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines

American Journal of Respiratory Cell and Molecular Biology

Volumn 25, Issue 1, 2001, Pages 111-118

  Liu, W ^a   Bodle, E ^a   Che, J Y ^a   Gao, M ^a   Rosen, G D ^a   Broaddus, V C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; ANTIINFECTIVE AGENT; APOPTOSIS; CELL LINE; CODON; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; DOXORUBICIN; EXPRESSION VECTOR; MESOTHELIOMA CELL; MITOCHONDRION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECEPTOR PROTEIN; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

BACTERIA (MICROORGANISMS);

EID: 0034914110     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.25.1.4472     Document Type: Article

References (40)

1. Chemotherapy in malignant pleural mesothelioma: A review
2. Apoptosis and drug response
3. Resistance of pleural mesothelioma cell lines to apoptosis: Relation to expression of Bcl-2 and Bax
4. p53 and Kirsten-ras mutations in human mesothelioma cell lines
5. Absence of p53 mutations in malignant mesotheliomas
6. Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells
7. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
8. Safety and antitumor activity of recombinant soluble Apo2 ligand
9. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
10. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
11. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
12. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics
13. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
14. Molecular determinants of response to TRAIL in killing of normal and cancer cells
15. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
16. Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL
17. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
18. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis
19. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity
20. Cisplatin at clinically relevant concentrations enhances interleukin-2 synthesis by human primary blood lymphocytes
21. A multidrug-resistant breast cancer cell line induced by weekly exposure to doxorubicin
22. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
23. Mesothelial cell apoptosis is confirmed in vivo by morphologic change in cytokeratin distribution
24. Preparation and characterization of an endogenously fluorescent annexin for detection of apoptotic cells
25. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species
26. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
27. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells
28. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
29. Death receptors: Signaling and modulation
30. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
31. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
32. Apoptosis: Checkpoint at the mitochondrial frontier
33. Mitochondrial control of cell death
34. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
35. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c
36. Two CD95 (APO-1/fas) signaling pathways
37. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release
38. Caspase-8 activation and Bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis
39. Caspases disrupt mitochondrial membrane barrier function
40. Mitochondria and apoptosis